UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients
2007 ◽
Vol 177
(4S)
◽
pp. 28-29
◽
1989 ◽
Vol 7
(1)
◽
pp. 27-41
◽
Keyword(s):
Keyword(s):
1994 ◽
Vol 49
(12)
◽
pp. 1088-1089
◽
Keyword(s):
Keyword(s):
Keyword(s):
1998 ◽
Vol 49
(2)
◽
pp. 176-178
2018 ◽
2018 ◽
Vol 13
(Number 1)
◽
pp. 55-67
Keyword(s):